Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is an Internet survey to collect data on the use of the Cefaly device to treat migraine attacks in regular Cefaly users.
About 1000 CEFALY users, having the device since more than one year and having reordered electrodes in the last year, will be invited to participate to an Internet survey. This survey contains at most 8 questions, and data will be collected completely anonymously. Questions concern the use or not of the CEFALY during migraine attacks, the number of treated attacks and the number and type of acute anti-migraine drugs that were avoided thanks to the use of the CEFALY.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Monthly number of acute drug intake avoided when using Cefaly to treat a migraine attack | On average, mean number of anti-migraine acute drug intake avoided per month per patient in regular Cefaly users, based on self reported average monthly number of attacks and percentage of attacks treated successfully with the Cefaly | Maximum 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of Cefaly users that report using also the device to treat migraine attacks | Percentage of regular Cefaly users using the device to treat attacks | Maximum 1 year |
| Proportion of migraine attacks treated with the Cefaly device |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
French speaking patients in Belgium, Switzerland and France, having ordered new electrodes during the last year will be identified as regular users.
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 28185179 | Result | Penning S, Schoenen J. A survey on migraine attack treatment with the CEFALY(R) device in regular users. Acta Neurol Belg. 2017 Jun;117(2):547-549. doi: 10.1007/s13760-017-0757-z. Epub 2017 Feb 9. No abstract available. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008881 | Migraine Disorders |
| ID | Term |
|---|---|
| D051270 | Headache Disorders, Primary |
| D020773 | Headache Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Percentage of migraine attacks treated with the Cefaly device by the Cefaly users
| Maximum 1 year |
| Proportion of migraine attacks for which the use of the Cefaly device generate a reduction of drug intake | Percentage of migraine attacks treated with the Cefaly device and for which the acute anti-migraine drug intake is reduced thanks to the Cefaly | Maximum 1 year |
| D009422 | Nervous System Diseases |